Role of Radiofrequency Ablation in Patients with Hepatocellular Carcinoma Who Undergo Prior Transarterial Chemoembolization: Long-Term Outcomes and Predictive Factors

BACKGROUND/AIMS: The role of radiofrequency ablation (RFA) remains uncertain in patients with viable hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE). METHODS: A total of 101 patients (April 2007 to August 2010) underwent RFA for residual or recurrent HCC after TACE. We an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sohn, Won, Choi, Moon Seok, Cho, Ju Yeon, Gwak, Geum-Youn, Paik, Yong-Han, Lee, Joon Hyeok, Koh, Kwang Cheol, Paik, Seung Woon, Yoo, Byung Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Gut and Liver 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164247/
https://www.ncbi.nlm.nih.gov/pubmed/25071073
http://dx.doi.org/10.5009/gnl13356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164247/
https://www.ncbi.nlm.nih.gov/pubmed/25071073
http://dx.doi.org/10.5009/gnl13356

Ejemplares similares